JAZZ vs. BMRN
Compare and contrast key facts about Jazz Pharmaceuticals plc (JAZZ) and BioMarin Pharmaceutical Inc. (BMRN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: JAZZ or BMRN.
Correlation
The correlation between JAZZ and BMRN is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
JAZZ vs. BMRN - Performance Comparison
Loading data...
Key characteristics
JAZZ:
-0.04
BMRN:
-0.66
JAZZ:
0.13
BMRN:
-0.81
JAZZ:
1.02
BMRN:
0.87
JAZZ:
-0.05
BMRN:
-0.41
JAZZ:
-0.26
BMRN:
-1.04
JAZZ:
10.31%
BMRN:
24.50%
JAZZ:
34.46%
BMRN:
35.13%
JAZZ:
-96.90%
BMRN:
-90.58%
JAZZ:
-43.54%
BMRN:
-60.26%
Fundamentals
JAZZ:
$6.72B
BMRN:
$11.37B
JAZZ:
$7.56
BMRN:
$2.70
JAZZ:
14.42
BMRN:
21.95
JAZZ:
3.89
BMRN:
0.84
JAZZ:
1.65
BMRN:
3.85
JAZZ:
1.57
BMRN:
1.93
JAZZ:
$4.06B
BMRN:
$2.94B
JAZZ:
$3.45B
BMRN:
$2.32B
JAZZ:
$1.28B
BMRN:
$738.30M
Returns By Period
In the year-to-date period, JAZZ achieves a -11.51% return, which is significantly lower than BMRN's -9.83% return. Over the past 10 years, JAZZ has outperformed BMRN with an annualized return of -4.95%, while BMRN has yielded a comparatively lower -7.43% annualized return.
JAZZ
-11.51%
6.03%
-10.42%
-0.01%
-1.20%
-4.95%
BMRN
-9.83%
0.17%
-6.54%
-23.58%
-9.10%
-7.43%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
JAZZ vs. BMRN — Risk-Adjusted Performance Rank
JAZZ
BMRN
JAZZ vs. BMRN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Jazz Pharmaceuticals plc (JAZZ) and BioMarin Pharmaceutical Inc. (BMRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
JAZZ vs. BMRN - Dividend Comparison
Neither JAZZ nor BMRN has paid dividends to shareholders.
Drawdowns
JAZZ vs. BMRN - Drawdown Comparison
The maximum JAZZ drawdown since its inception was -96.90%, which is greater than BMRN's maximum drawdown of -90.58%. Use the drawdown chart below to compare losses from any high point for JAZZ and BMRN. For additional features, visit the drawdowns tool.
Loading data...
Volatility
JAZZ vs. BMRN - Volatility Comparison
Jazz Pharmaceuticals plc (JAZZ) has a higher volatility of 15.98% compared to BioMarin Pharmaceutical Inc. (BMRN) at 9.26%. This indicates that JAZZ's price experiences larger fluctuations and is considered to be riskier than BMRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
JAZZ vs. BMRN - Financials Comparison
This section allows you to compare key financial metrics between Jazz Pharmaceuticals plc and BioMarin Pharmaceutical Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
JAZZ vs. BMRN - Profitability Comparison
JAZZ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Jazz Pharmaceuticals plc reported a gross profit of 793.22M and revenue of 897.84M. Therefore, the gross margin over that period was 88.4%.
BMRN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, BioMarin Pharmaceutical Inc. reported a gross profit of 593.59M and revenue of 745.15M. Therefore, the gross margin over that period was 79.7%.
JAZZ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Jazz Pharmaceuticals plc reported an operating income of -55.89M and revenue of 897.84M, resulting in an operating margin of -6.2%.
BMRN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, BioMarin Pharmaceutical Inc. reported an operating income of 223.89M and revenue of 745.15M, resulting in an operating margin of 30.1%.
JAZZ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Jazz Pharmaceuticals plc reported a net income of -92.54M and revenue of 897.84M, resulting in a net margin of -10.3%.
BMRN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, BioMarin Pharmaceutical Inc. reported a net income of 185.69M and revenue of 745.15M, resulting in a net margin of 24.9%.